tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
Want to see HK:3692 full AI Analyst Report?

Hansoh Pharmaceutical Group Company Limited (3692) Income Statement

8 Followers

Hansoh Pharmaceutical Group Company Limited Income Statement

Last quarter (Q4 2025), Hansoh Pharmaceutical Group Company Limited's total revenue was ¥7.59B, an increase of 35.80% from the same quarter last year. In Q4, Hansoh Pharmaceutical Group Company Limited's net income was ¥2.42B. See Hansoh Pharmaceutical Group Company Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 15.03B¥ 12.26B¥ 10.10B¥ 9.38B¥ 9.94B
Gross Profit
¥ 13.51B¥ 11.16B¥ 9.07B¥ 8.51B¥ 9.06B
Operating Expenses
¥ 8.09B¥ 7.12B¥ 6.23B¥ 5.84B¥ 6.17B
Depreciation and Amortization
¥ 364.36M¥ 375.57M¥ 366.38M¥ 324.37M¥ 278.47M
EBITDA
¥ 5.77B¥ 4.28B¥ 4.20B¥ 2.93B¥ 3.08B
Operating Income
¥ 5.42B¥ 4.03B¥ 2.84B¥ 2.67B¥ 2.90B
Other Income/Expenses
¥ 1.13B¥ 1.05B¥ 926.83M¥ 277.21M¥ 403.58M
Pretax Income
¥ 6.55B¥ 5.09B¥ 3.77B¥ 2.95B¥ 3.30B
Net Income
¥ 5.56B¥ 4.37B¥ 3.28B¥ 2.58B¥ 2.71B
Per Share Metrics
Basic EPS
¥ 0.93¥ 0.74¥ 0.50¥ 0.44¥ 0.46
Diluted EPS
¥ 0.93¥ 0.73¥ 0.52¥ 0.44¥ 0.44
Weighted Average Shares Outstanding
5.98B 5.93B 6.27B 5.92B 5.92B
Weighted Average Shares Outstanding (Diluted)
5.98B 5.95B 6.02B 5.93B 6.00B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History